The presence of SH3TC2-DT and SH3TC2 in respective prognostic risk models emphasized the importance of this divergent lncRNA/mRNA gene pair in prognosis of FLT3-mutant AML (Tables 1, 2), but interestingly, the expression of the SH3TC2-DT/SH3TC2 gene pair showed no significant difference between FLT3-ITD and FLT3-TKD AML samples (Figure S3). This evidence concerns the gene SH3TC2 and acute myeloid leukemia.